Moderna Provides Business Updates and Reports Third Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. RTX
6. COF
7. SMCI
8. TSLA
9. BRZE
10. GOOGL

Go back to Moderna Provides Business Updates and Reports Third Quarter 2019 Financial Results

Moderna (MRNA) Reports Q3 EPS Revenues Miss

November 6, 2019 7:19 AM EST

Moderna (NASDAQ: MRNA) reported Q3 revenue for the quarter came in at $17.05 million versus the consensus estimate of $18.36 million.

Third Quarter 2019 Financial Results

Cash Position: Cash, cash equivalents and investments as of September 30, 2019 and December 31, 2018 were $1.34 billion and $1.69 billion, respectively.Net Cash Used in Operating Activities: Net cash used in operating activities was $363.2 million for the nine months ended September 30, 2019 compared to $239.8 million for the same period in 2018. Net cash used in operating activities includes $22.0 million and $25.0 million for the nine months ended September 30, 2019 and 2018, respectively, of in-licensing payments to Cellscript, LLC... More